Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years
about
Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score methodFOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease.
P2860
Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical utility and diagnosti ...... ces in adults aged 16-50 years
@ast
Clinical utility and diagnosti ...... ces in adults aged 16-50 years
@en
type
label
Clinical utility and diagnosti ...... ces in adults aged 16-50 years
@ast
Clinical utility and diagnosti ...... ces in adults aged 16-50 years
@en
prefLabel
Clinical utility and diagnosti ...... ces in adults aged 16-50 years
@ast
Clinical utility and diagnosti ...... ces in adults aged 16-50 years
@en
P2093
P2860
P1476
Clinical utility and diagnosti ...... ces in adults aged 16-50 years
@en
P2093
Andrew Walkden
Annalie Clark
Brydon W Gordon
Federica Fascí-Spurio
Ian D R Arnott
Jack Satsangi
Jeff C W Chang
Kathleen Kingstone
Martina Muscat
P2860
P356
10.1016/J.CROHNS.2014.07.005
P577
2015-01-01T00:00:00Z